Metoprolol dosage and effects on heart rate
Pro Research Analysisby 
Searched over 200M research papers
Metoprolol Dosage Forms and Heart Rate Reduction
Metoprolol is available in different formulations, including immediate-release (IR) and controlled-release/extended-release (CR/XL or succinate sustained-release) tablets. Studies comparing these forms show that both are effective in reducing heart rate, but higher doses and extended-release forms may provide a more pronounced and sustained effect. For example, metoprolol CR/XL 200 mg once daily led to a greater reduction in heart rate compared to IR 50 mg three times daily, especially during exercise, while maintaining similar peak plasma levels. Both regimens were well tolerated and safe for switching between forms in patients with heart failure . In patients with chronic congestive heart failure, metoprolol succinate sustained-release tablets reduced average heart rate more than metoprolol tartrate tablets, though both had similar effects on cardiac and renal function .
Dose-Response Relationship and Heart Rate Control
The reduction in heart rate with metoprolol is dose-dependent. Both 50 mg and 80 mg oral doses significantly lowered heart rate in patients with mild hypertension, with the effect being linearly related to the logarithm of plasma concentration. This relationship was consistent in both acute and steady-state dosing, and similar to effects seen in healthy volunteers during exercise . In clinical practice, titrating the dose to achieve a target heart rate (often 60–70 bpm in heart failure) is common. In a study of patients undergoing CT coronary angiography, a single 100 mg dose of metoprolol was more effective and faster at reducing heart rate to below 70 bpm compared to an initial 50 mg dose with an additional 25 mg if needed, without increasing side effects .
Metoprolol in Acute Myocardial Infarction and Heart Failure
In patients with acute myocardial infarction, both metoprolol succinate sustained-release and tartrate tablets reduced heart rate over the first 72 hours, with no significant difference in the degree or trend of heart rate reduction between the two forms . In patients with low baseline heart rates (≤65 bpm) and acute myocardial infarction, intravenous and oral metoprolol led to a 10–20% reduction in heart rate, with the most pronounced effect immediately after administration. Tolerance was good, and the hemodynamic response was similar to that in patients with higher baseline heart rates .
For chronic heart failure, gradual dose escalation is recommended to avoid excessive bradycardia or hypotension. In one study, the average tolerated dose was about 70 mg/day, with most patients maintaining heart rates above 50 bpm and good overall safety . Another study found that both lower (47.5 mg) and higher (118.75 mg) doses of metoprolol were equally effective in improving cardiac function, motor function, and quality of life, suggesting that lower doses may be sufficient for many patients . Similar findings were observed in a larger cohort, where dose increases did not significantly change cardiac index or quality of life, though some psychological effects varied by gender .
Effects on Heart Rate Variability
Metoprolol, like other beta-blockers, increases heart rate variability in patients with coronary artery disease, which is considered beneficial for cardiac autonomic control. Both metoprolol and atenolol significantly increased measures of heart rate variability, with no significant difference between the two drugs .
Conclusion
Metoprolol effectively reduces heart rate in a dose-dependent manner across various cardiovascular conditions, including hypertension, heart failure, and acute myocardial infarction. Extended-release formulations and higher doses provide more sustained heart rate control, but lower doses may be equally effective for many patients, especially in chronic heart failure. Both immediate and extended-release forms are well tolerated, and the choice of formulation and dose should be individualized based on patient response and clinical goals 1234+6 MORE.
Sources and full results
Most relevant research papers on this topic